Nadiye AKDENİZ, Halis YERLİKAYA, Abdurrahman IŞIKDOĞAN, Mehmet KÜÇÜKÖNER, Oğur KARHAN, Muhammet Ali KAPLAN, Fatma TEKE, Zuhat URAKÇI

Rare Occurrence of Synovial Sarcoma Originating from Dura Mater

Primary or metastatic dura mater sarcomas are rarely seen, and dural synovial sarcomas are quite rare.Here we report the case of a 60-year-old man who presented with headache, nausea, and vomiting andwas found to have a 63×33×40-mm mass with solid and cystic components in parieto-occipital lobe. Themass was resected completely, with no residue detected on postoperative magnetic resonance imagining.On pathological evaluation, a vimentin-, S100-, transducer-like enhancer of split 1-, BCL-2-, and EMApositive and desmin-, PR-, CD99-, PANCK-, and GFAP-negative synovial sarcoma with Ki-67 proliferation index of 12% was detected. Postoperatively, chemotherapy has been started, and it will be followed byradiotherapy. Primary meningeal-derived sarcomas are rare, and differential diagnosis with other meningeal mesenchymal tumors is based on the findings of morphological and immunohistochemical analyses.

PDF

___

1. Sharma S, Sharma A, Lobo G, Nayak M, Pradhan D, Samriti, et al. Primary dura-based synovial sarcoma of the parafalcine region of brain. Pathol Res Pract 2017;213(7):868–71.
2. World Health Organization. World Health Organization Classification of Tumours. In: Fletcher CDM, Unni KK, Mertens F, editors. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC; 2002. p. 200–04.
3. World Health Organization. In: Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization Classification of Soft Tissue Tumors. 4th ed. Lyon: IARC; 2013. p. 213–15.
4. Ji T, Ma CY, Ow A, Wang LZ, Sun J, Zhang CP. Synovial sarcoma involving skull base-a retrospective analysis of diagnosis and treatment of 21 cases in one institution. Oral Oncol 2011;47(7):671–6.
5. Ghadially FN. Is synovial sarcoma a carcinosarcoma of connective tissue? Ultrastruct Pathol 1987;11(2- 3):147–51.
6. Fletcher C. Tumors of soft tissue. Diagnostic Histopathology of Tumors. In: Fletcher C, editor. 4th ed. Philadelphia: Elsevier-Saunders; 2013. p. 1847– 49.
7. Horbinski C, Cieply K, Bejjani GK, McFadden K. Primary intracranial dural-based synovial sarcoma with an unusual SYT fluorescence in situ hybridization pattern. J Neurosurg 2008;109(5):897–903.
8. Goldblum JR, Weiss SW, Folpe AL. Malignant Soft Tissue Tumors of Uncertain Type. In: Enzinger and Weiss’s Soft Tissue Tumors. 6th ed. Philadelphia: Elsevier-Saunders; 2014. p. 1052–70.
9. Lin YJ, Yang QX, Tian XY, Li B, Li Z. Unusual primary intracranial dural-based poorly differentiated synovial sarcoma with t(X; 18)(p11; q11). Neuropathology 2013;33(1):75–82.
10.Nuwal P, Dixit R, Shah NS, Samaria A. Primary monophasic synovial sarcoma lung with brain metastasis diagnosed on transthoracic FNAC: Report of a case with literature review. Lung India 2012;29(4):384–7.
11.Rajwanshi A, Srinivas R, Upasana G. Malignant small round cell tumors. J Cytol 2009;26(1):1–10.
12.Carneiro SS, Scheithauer BW, Nascimento AG, Hirose T, Davis DH. Solitary fibrous tumor of the meninges: a lesion distinct from fibrous meningioma. A clinicopathologic and immunohistochemical study. Am J Clin Pathol 1996;106(2):217–24.
13.Abdelzaher E, Abdallah DM. Expression of mesothelioma-related markers in meningiomas: an immunohistochemical study. Biomed Res Int 2014;2014:968794.
14.Hsu DW, Efird JT, Hedley-Whyte ET. Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 1997;86(1):113–20.
15.Folpe AL, Schmidt RA, Chapman D, Gown AM. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol 1998;22(6):673–82.
16.Smith TA, Machen SK, Fisher C, Goldblum JR. Usefulness of cytokeratin subsets for distinguishing monophasic synovial sarcoma from malignant peripheral nerve sheath tumor. Am J Clin Pathol 1999;112(5):641–8.
17.Foo WC, Cruise MW, Wick MR, Hornick JL. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Am J Clin Pathol 2011;135(6):839–44.
18.Guadagnolo BA, Zagars GK, Ballo MT, Patel SR, Lewis VO, Pisters PW, et al. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 2007;69(4):1173–80.
19.Baptista AM, Camargo OP, Croci AT, Oliveira CR, Azevedo Neto RS, Giannotti MA, et al. Synovial sarcoma of the extremities: prognostic factors for 20 nonmetastatic cases and a new histologic grading system with prognostic significance. Clinics (Sao Paulo) 2006;61(5):381–6.